Immix Biopharma logo

Immix Biopharma

IMMX | NASDAQ
Chart Builder DCF Calculator
$7.48
-$0.36 (-4.59%)
At close: Nov 16, 2026, 4:00 PM ET
$7.48
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-4.59%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
26
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #903/1021 (Top 88%)

Key Statistics

Market Data

Market Cap $626.92M
1D Range
7.46 8.01
52W Range
3.97 14.47

Valuation (TTM)

PE -9.01
PB 1.87
EV/EBITDA -6.27

Valuation (NTM)

Forward PE 7.73
Forward PEG -1.25
Price Target $23.00
Loading financial charts...

Profile

Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies. Operating in both the United States and Australia, their primary focus areas ar...

Sector Healthcare
Industry Biotechnology
Employees 21
IPO Date Dec 16, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$23.00
Upside
+207.49%
Buy (5)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.